SIGLEC6
SIGLEC6 (sialic acid binding Ig like lectin 6, also known as CD327, OB-BP1, SIGLEC-6, CD33L and CD33L1) is a putative adhesion molecule of the SIGLEC family. It mediates sialic-acid dependent binding to cells and is a member of the immunoglobulin superfamily. Browse Assay Genie's current range of SIGLEC6 research reagents below, or read on for the biology behind the target.
SIGLEC6 is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It binds to alpha-2,6-linked sialic acid. Its sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface, which means that access to ligands can depend on the glycan environment of the cell on which the protein sits. The encoded transmembrane receptor also binds sialyl-TN glycans and leptin.
The SIGLEC6 gene encodes a member of the SIGLEC (sialic acid binding immunoglobulin-like lectin) family and the immunoglobulin superfamily. HGNC places it in the groups of CD molecules, V-set domain containing, I-set domain containing and sialic acid binding Ig like lectins. UniProt lists its subcellular locations as the cell membrane and secreted, so the SIGLEC6 protein is found both as a membrane-bound receptor and in a secreted form. Researchers looking for a SIGLEC6 antibody or SIGLEC6 ELISA kit will often be interested in these two forms and in the glycan-binding behaviour of the molecule.
SIGLEC6 has been known under several names, including OB-BP1, SIGLEC-6, CD33L, CD33L1 and the CD designation CD327. The OB-BP1 alias is consistent with its reported binding to leptin. In disease-related work, RefSeq notes that placental expression of the encoded protein is upregulated in preeclampsia, which makes SIGLEC6 a point of interest in placental biology and pregnancy research.
SIGLEC6 binds alpha-2,6-linked sialic acid and sialyl-TN glycans, making it a useful model for studying sialic-acid dependent recognition.
As a putative adhesion molecule, SIGLEC6 mediates sialic-acid dependent binding to cells, and cis interactions may mask its recognition site.
Placental expression of SIGLEC6 is upregulated in preeclampsia, linking the protein to studies of pregnancy-related disease.
The SIGLEC6 receptor binds leptin, which is relevant to work on this interaction and on the OB-BP1 name.
SIGLEC6 is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It binds alpha-2,6-linked sialic acid, and its recognition site may be masked by cis interactions with sialic acids on the same cell surface. It also binds sialyl-TN glycans and leptin.
SIGLEC6 is also called SIGLEC-6, OB-BP1, CD327, CD33L and CD33L1. The full name is sialic acid binding Ig like lectin 6. UniProt describes the protein as Sialic acid-binding Ig-like lectin 6, and it belongs to the SIGLEC family.
RefSeq reports that placental expression of SIGLEC6 is upregulated in preeclampsia. Beyond this, the supplied sources do not describe other disease associations. Mouse and rat orthologs are not specified in the data, so check the datasheet of any product for its validated reactivity.
Other SIGLEC family members and sialic acid-binding immunoglobulin-like lectins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43699; product specifications from Assay Genie datasheets.